About the IMEDS Steering Committee

The IMEDS Steering Committee (SC) provides programmatic oversight and guidance on the operation of IMEDS. Steering Committee responsibilities include advising on strategic direction, integrating IMEDS within the research community, and providing input on IMEDS program activities.

The 12-member Steering Committee is comprised of two FDA non-voting members and 10 voting members representing health insurers, health systems, patient advocacy groups, regulated industries, academia, and research institutes. 

IMEDS Steering Committee Members

Jacqueline Corrigan-Curay, JD, MD
Principal Deputy Center Director, Center for Drug Evaluation and Research 
US Food & Drug Administration

Sascha Dublin, MD, PhD 
Senior Investigator, Kaiser Permanente Washington Health Research Institute
Physician, Washington Permanente Medical Group, Internal Medicine

Carlos Garner
Vice President, Global Regulatory Affairs
Eli Lilly & Company

Solomon Iyasu, MD, MPH
Vice President and Head of Pharmacoepidemiology

Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research
US Food & Drug Administration

Vinit Nair, BPhar, MS
Health Plan Research Network Principal Investigator

Sally Okun, RN
SallyOkun360 LLC

Bray Patrick-Lake, MFS
Director, Strategic Partnerships
Evidation Health

The Steering Committee charge is awaiting approval.